Cargando…

Fall in C-Peptide During First 4 Years From Diagnosis of Type 1 Diabetes: Variable Relation to Age, HbA(1c), and Insulin Dose

OBJECTIVE: We aimed to describe the natural history of residual insulin secretion in Type 1 Diabetes TrialNet participants over 4 years from diagnosis and relate this to previously reported alternative clinical measures reflecting β-cell secretory function. RESEARCH DESIGN AND METHODS: Data from 407...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hao, Wei, Gitelman, Steven, DiMeglio, Linda A., Boulware, David, Greenbaum, Carla J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2016
Materias:	Clinical Care/Education/Nutrition/Psychosocial Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033079/ https://www.ncbi.nlm.nih.gov/pubmed/27422577 http://dx.doi.org/10.2337/dc16-0360

Ejemplares similares

Inpatient HbA1c testing: a prospective observational study
por: Nanayakkara, Natalie, et al.
Publicado: (2015)

HbA(1c) and the Prediction of Type 2 Diabetes in Children and Adults
por: Vijayakumar, Pavithra, et al.
Publicado: (2017)

Glucose Regulation Beyond HbA(1c) in Type 2 Diabetes Treated With Insulin: Real-World Evidence From the DIALECT-2 Cohort
por: den Braber, Niala, et al.
Publicado: (2021)

Performance of HbA(1c) and Fasting Plasma Glucose in Screening for Diabetes in Patients Undergoing Coronary Angiography
por: Wang, Jun-Sing, et al.
Publicado: (2013)

Diabetes case finding in the emergency department, using HbA1c: an opportunity to improve diabetes detection, prevention, and care
por: Hng, Tien-Ming, et al.
Publicado: (2016)

Integrative health coaching: a behavior skills approach that improves HbA1c and pharmacy claims-derived medication adherence
por: Wolever, Ruth Q, et al.
Publicado: (2016)

HbA(1c) After a Short Period of Monotherapy With Metformin Identifies Durable Glycemic Control Among Adolescents With Type 2 Diabetes
por: Zeitler, Phil, et al.
Publicado: (2015)

Validation and feasibility of a postal system for remote monitoring of HbA1c
por: Cross, Jen, et al.
Publicado: (2021)

The Association Between HbA(1c) and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4)
por: Seyed Ahmadi, Shilan, et al.
Publicado: (2020)

Effect of baseline HbA1c level on the development of diabetes by lifestyle intervention in primary healthcare settings: insights from subanalysis of the Japan Diabetes Prevention Program
por: Sakane, Naoki, et al.
Publicado: (2014)

HbA(1c) Reduction in Dulaglutide-Treated Patients Irrespective of Duration of Diabetes, Microvascular Disease, and BMI: A Post Hoc Analysis From the REWIND Trial
por: Kwan, Anita Y.M., et al.
Publicado: (2022)

Variables associated with HbA1c and weight reductions when adding liraglutide to multiple daily insulin injections in persons with type 2 diabetes (MDI Liraglutide trial 3)
por: Dahlqvist, Sofia, et al.
Publicado: (2018)

HbA1c response and hospital admissions following commencement of flash glucose monitoring in adults with type 1 diabetes
por: Stimson, Roland H, et al.
Publicado: (2020)

Better HbA1c during the first years after diagnosis of type 1 diabetes is associated with residual C peptide 10 years later
por: Grönberg, Annika, et al.
Publicado: (2020)

HbA1c reduction following flash monitoring commencement is not independently associated with adverse diabetic eye disease outcomes in type 1 diabetes
por: Al-Dalla Ali, Muhammad, et al.
Publicado: (2020)

Responses to the Strengths and Difficulties Questionnaire predict HbA1c trajectories in children and adolescents with type 1 diabetes: a population-based study
por: Marks, Kevin P, et al.
Publicado: (2023)

Parental diabetes distress is a stronger predictor of child HbA1c than diabetes device use in school-age children with type 1 diabetes
por: Patton, Susana R, et al.
Publicado: (2023)

Effect of regular exercise training on changes in HbA1c, BMI and VO(2)max among patients with type 2 diabetes mellitus: an 8-year trial
por: Najafipour, Farzad, et al.
Publicado: (2017)

HbA1c performs well in monitoring glucose control even in populations with high prevalence of medical conditions that may alter its reliability: the OPTIMAL observational multicenter study
por: Niwaha, Anxious J, et al.
Publicado: (2021)

Urinary C peptide creatinine ratio in pregnant women with normal glucose tolerance and type 1 diabetes: evidence for insulin secretion
por: Markoska, Ankica, et al.
Publicado: (2017)

Comparison of Glycemic Variability Associated With Insulin Glargine and Intermediate-Acting Insulin When Used as the Basal Component of Multiple Daily Injections for Adolescents With Type 1 Diabetes
por: White, Neil H., et al.
Publicado: (2009)

Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of β-Cell Function in Therapeutic Trials in Type 1 Diabetes
por: Greenbaum, Carla J., et al.
Publicado: (2008)

The True Value of HbA1c as a Predictor of Diabetic Complications: Simulations of HbA1c Variables
por: Lind, Marcus, et al.
Publicado: (2009)

Influence of and Optimal Insulin Therapy for a Low–Glycemic Index Meal in Children With Type 1 Diabetes Receiving Intensive Insulin Therapy
por: Ryan, Rochelle L., et al.
Publicado: (2008)

A1C but Not Serum Glycated Albumin Is Elevated in Late Pregnancy Owing to Iron Deficiency
por: Hashimoto, Kunihiko, et al.
Publicado: (2008)

Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes
por: Sarkar, Gayatri, et al.
Publicado: (2014)

Effects of Frequency of Sensor-Augmented Pump Use on HbA(1c) and C-Peptide Levels in the First Year of Type 1 Diabetes
por: Triolo, Taylor M., et al.
Publicado: (2016)

Effect of Age of Infusion Site and Type of Rapid-Acting Analog on Pharmacodynamic Parameters of Insulin Boluses in Youth With Type 1 Diabetes Receiving Insulin Pump Therapy
por: Swan, Karena L., et al.
Publicado: (2009)

Momentary Predictors of Insulin Restriction Among Adults With Type 1 Diabetes and Eating Disorder Symptomatology
por: Merwin, Rhonda M., et al.
Publicado: (2015)

Blood glucose self-monitoring and internet diabetes management on A1C outcomes in patients with type 2 diabetes
por: Chow, Nelson, et al.
Publicado: (2016)

Comparison of Once- Versus Twice-Daily Administration of Insulin Detemir, Used With Mealtime Insulin Aspart, in Basal-Bolus Therapy for Type 1 Diabetes: Assessment of Detemir Administration in a Progressive Treat-To-Target Trial (ADAPT)
por: Le Floch, Jean-Pierre, et al.
Publicado: (2009)

The Adaptation of the Carbohydrate Counting Method Affects HbA1c and Improves Anthropometric Indicators in Patients With Diabetes Mellitus 2
por: Di Iorio, Adriana Beatriz, et al.
Publicado: (2021)

Is a Priming Dose of Insulin Necessary in a Low-Dose Insulin Protocol for the Treatment of Diabetic Ketoacidosis?
por: Kitabchi, Abbas E., et al.
Publicado: (2008)

Determining starting basal rates of insulin infusion for insulin pump users: a comparison between methods
por: Chow, Nelson, et al.
Publicado: (2016)

Effects of Dietary n-3 Fatty Acids on Hepatic and Peripheral Insulin Sensitivity in Insulin-Resistant Humans
por: Lalia, Antigoni Z., et al.
Publicado: (2015)

Optimizing Postprandial Glycemia in Pediatric Patients With Type 1 Diabetes Using Insulin Pump Therapy: Impact of glycemic index and prandial bolus type
por: O'Connell, Michele A., et al.
Publicado: (2008)

Insulin therapy and dietary adjustments to normalize glycemia and prevent nocturnal hypoglycemia after evening exercise in type 1 diabetes: a randomized controlled trial
por: Campbell, Matthew D, et al.
Publicado: (2015)

A Randomized Trial Evaluating the Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec With or Without Metformin, in Adults With Type 2 Diabetes (ONSET 9)
por: Lane, Wendy S., et al.
Publicado: (2020)

Insulin Dose and Cardiovascular Mortality in the ACCORD Trial
por: Siraj, Elias S., et al.
Publicado: (2015)

Extended insulin boluses cannot control postprandial glycemia as well as a standard bolus in children and adults using insulin pump therapy
por: Lopez, Prudence, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7bibtajef67a4q4f1heb6eoftm